• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
Marjorie Eiref (left) and Beata Henry getting the job done
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/From Our Labs

Women in Science: Marjorie Eiref

Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.

By
Susan C. DiClemente
Oct 10, 2018

Marjorie Eiref
Marjorie Eiref, Head of Operations, Neuroscience Research, Novartis

Many people who work in the healthcare industry do so because they want to help people. For Marjorie Eiref, family also plays a key role. Eiref, who serves as Head of Operations for Neuroscience Research at Novartis, explains how her family medical history has helped shape her 25-year career in pharmaceutical research operations.

What motivates you to work in the healthcare industry?

I have worked in pharmaceutical research operations for 25 years. The reason that I love my work and why I wake up every morning excited about coming to Novartis is because I’m very passionate about drug discovery, specifically in the neuroscience field. One in three Americans is affected by a psychiatric or neurodegenerative disease. I have a brother who is autistic. He is 47 years old and lives in a group home. I am his legal guardian. My uncle was a Vietnam veteran with classic schizophrenia. My grandmother had Alzheimer’s, and I watched her slow debilitation. When I sit in lab meetings or in leadership team meetings, I am always thinking about my family and how our research and decisions relate back to all affected patients and their families and caregivers. Every decision we make in early research has an impact eventually on these people and their comfort, happiness and livelihood.

You can do it! Work hard. Stay focused. Help others. Have fun. It’s all good!

Marjorie Eiref, Head of Operations, Neuroscience Research

What personal qualities or experiences have you leveraged to achieve your goals?

My three greatest personal strengths are compassion, loyalty and courage. But I think my vulnerabilities and weaknesses are the things that have made me stronger in my life. I have been a single mom for over 12 years. Both of my children are happy and doing well in their university studies. But the early years, when they were younger and I was working full-time, were very challenging. One of the ways that I survived was to be actively involved, to always volunteer whenever I could help out with watching other people’s children [and] helping at soccer games or school events. I never knew when I might need to call in a favor from someone else. This applies to our careers; if you do things to help your community – truly support other people – it always comes back to help you. Karma exists. It is important to be generous and supportive of others. It takes a village to accomplish many things, and we have an amazing community at Novartis.

What opportunities have helped you advance in your career, and how will you pay it forward?

I have been very fortunate. The first woman who I worked for was not just a manager but a mentor. Since then, it has always been very important for me to mentor other people, especially women. When people reach out for advice about career development, professional job skills, recruitment opportunities, I am always eager to help or share my perspective. It is important to network and bridge our knowledge and skills with others. 

Shareline

Marjorie Eiref, one of our #WomenInScience, says her personal connection to certain diseases is the motivation behind her work
Tweet Tweetpopo

Reimagine medicine with Novartis

We are reimaging neuroscience medicine. We’re looking for innovative researchers who push the boundaries of science.

Learn More

Tags: 
Neuroscience, Novartis Institutes for BioMedical Research, Women in Science, Working at Novartis, Reimagine Medicine

Susan C. DiClemente

Susan C. DiClemente

is a Director of Communications at the Novartis Institutes for BioMedical Research.

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Coronavirus
From Our Labs

A visual tour of scientific strategies for combating coronavirus

Wendi Yajnik, Global Head of Academic Partnerships and External Innovation for research
From Our Labs

Advancing medicine through collaboration

Special instrument controlled by a production associate
From Our Labs

Turning the power of nuclear technology into a medical force

You are here

  1. Home ›
  2. Stories ›
  3. From Our Labs

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.